Report Detail

Medical Devices & Consumables Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Research Report 2021

  • RnM4299892
  • |
  • 05 April, 2021
  • |
  • Global
  • |
  • 98 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Overview

  • 1.1 Product Overview and Scope of Non-alcoholic Steatohepatitis (NASH) Biomarkers
  • 1.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Segment by Type
    • 1.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Serum Biomarkers
    • 1.2.3 Cytokeratin-18 (CK 18) Marker
    • 1.2.4 Inflammatory Markers
    • 1.2.5 Others
  • 1.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Segment by Application
    • 1.3.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals
    • 1.3.3 Diagnostic Centers
    • 1.3.4 Others
  • 1.4 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size Estimates and Forecasts
    • 1.4.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue 2016-2027
    • 1.4.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales 2016-2027
    • 1.4.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Region: 2016 Versus 2021 Versus 2027

2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competition by Manufacturers

  • 2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Sites, Area Served, Product Type
  • 2.5 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competitive Situation and Trends
    • 2.5.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Non-alcoholic Steatohepatitis (NASH) Biomarkers Players Market Share by Revenue
    • 2.5.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Retrospective Market Scenario by Region

  • 3.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country
    • 3.3.1 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country
    • 3.3.2 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country
    • 3.4.1 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country
    • 3.4.2 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region
    • 3.5.2 Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country
    • 3.6.1 Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country
    • 3.6.2 Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country
    • 3.7.2 Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Historic Market Analysis by Type

  • 4.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2016-2021)
  • 4.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Type (2016-2021)
  • 4.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price by Type (2016-2021)

5 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Historic Market Analysis by Application

  • 5.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2016-2021)
  • 5.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Application (2016-2021)
  • 5.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Biopredictive
    • 6.1.1 Biopredictive Corporation Information
    • 6.1.2 Biopredictive Description and Business Overview
    • 6.1.3 Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Biopredictive Product Portfolio
    • 6.1.5 Biopredictive Recent Developments/Updates
  • 6.2 Quest Diagnostics
    • 6.2.1 Quest Diagnostics Corporation Information
    • 6.2.2 Quest Diagnostics Description and Business Overview
    • 6.2.3 Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Quest Diagnostics Product Portfolio
    • 6.2.5 Quest Diagnostics Recent Developments/Updates
  • 6.3 Exalenz Bioscience
    • 6.3.1 Exalenz Bioscience Corporation Information
    • 6.3.2 Exalenz Bioscience Description and Business Overview
    • 6.3.3 Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Exalenz Bioscience Product Portfolio
    • 6.3.5 Exalenz Bioscience Recent Developments/Updates
  • 6.4 GENFIT
    • 6.4.1 GENFIT Corporation Information
    • 6.4.2 GENFIT Description and Business Overview
    • 6.4.3 GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 GENFIT Product Portfolio
    • 6.4.5 GENFIT Recent Developments/Updates
  • 6.5 Siemens Healthineers
    • 6.5.1 Siemens Healthineers Corporation Information
    • 6.5.2 Siemens Healthineers Description and Business Overview
    • 6.5.3 Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Siemens Healthineers Product Portfolio
    • 6.5.5 Siemens Healthineers Recent Developments/Updates
  • 6.6 ONE WAY LIVER
    • 6.6.1 ONE WAY LIVER Corporation Information
    • 6.6.2 ONE WAY LIVER Description and Business Overview
    • 6.6.3 ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 ONE WAY LIVER Product Portfolio
    • 6.6.5 ONE WAY LIVER Recent Developments/Updates
  • 6.7 Prometheus Laboratories
    • 6.6.1 Prometheus Laboratories Corporation Information
    • 6.6.2 Prometheus Laboratories Description and Business Overview
    • 6.6.3 Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Prometheus Laboratories Product Portfolio
    • 6.7.5 Prometheus Laboratories Recent Developments/Updates
  • 6.8 Gilead Sciences
    • 6.8.1 Gilead Sciences Corporation Information
    • 6.8.2 Gilead Sciences Description and Business Overview
    • 6.8.3 Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Gilead Sciences Product Portfolio
    • 6.8.5 Gilead Sciences Recent Developments/Updates

7 Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Cost Analysis

  • 7.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Non-alcoholic Steatohepatitis (NASH) Biomarkers
  • 7.4 Non-alcoholic Steatohepatitis (NASH) Biomarkers Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Distributors List
  • 8.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Customers

9 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Dynamics

  • 9.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Industry Trends
  • 9.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Growth Drivers
  • 9.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Challenges
  • 9.4 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Restraints

10 Global Market Forecast

  • 10.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Type (2022-2027)
  • 10.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Application (2022-2027)
  • 10.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Serum Biomarkers
    Cytokeratin-18 (CK 18) Marker
    Inflammatory Markers
    Others

    Segment by Application
    Hospitals
    Diagnostic Centers
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Biopredictive
    Quest Diagnostics
    Exalenz Bioscience
    GENFIT
    Siemens Healthineers
    ONE WAY LIVER
    Prometheus Laboratories
    Gilead Sciences


    Summary:
    Get latest Market Research Reports on Non-alcoholic Steatohepatitis (NASH) Biomarkers. Industry analysis & Market Report on Non-alcoholic Steatohepatitis (NASH) Biomarkers is a syndicated market report, published as Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Research Report 2021. It is complete Research Study and Industry Analysis of Non-alcoholic Steatohepatitis (NASH) Biomarkers market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,114.98
    3,172.48
    4,229.97
    2,436.61
    3,654.92
    4,873.23
    318,115.50
    477,173.25
    636,231.00
    216,836.48
    325,254.72
    433,672.96
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report